CA
NUVB icon

Clearstead Advisors’s Nuvation Bio NUVB Stock Holding History

Clearstead Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$961 Buy
+169
New +$826 ﹤0.01% 2708
2026
Q1 		– Sell
-30
Closed -$269 – 2661
2025
Q4 		$269 Sell
30
-1,205
-98% -$7.46K ﹤0.01% 2391
2025
Q3 		$4.57K Buy
1,235
+744
+152% +$2.03K ﹤0.01% 2188
2025
Q2 		$958 Buy
+491
New +$1.02K ﹤0.01% 2436

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Clearstead Advisors's NUVB Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Nuvation Bio (NUVB) in Q2 2026: 169 shares worth $961. The stake represents ﹤0.01% of the portfolio and ranks #2708 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in NUVB as recently as Q4 2025.

Clearstead Advisors first reported a position in NUVB in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.57K in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Clearstead Advisors held 169 shares of Nuvation Bio worth $961 as of Q2 2026.
  • Nuvation Bio was a new Clearstead Advisors position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2708 holding.
  • Clearstead Advisors first reported a position in Nuvation Bio in Q2 2025 and has held it in 4 quarters since.
  • Clearstead Advisors's Nuvation Bio position peaked at $4.57K in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.